SCHEMBL14723767

SCHEMBL14723767

CCC(C)(C)C(=O)c1nc(Cl)cc2ccccc12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 2/20 0.38
RIPK1 Q13546 4/20 0.37
KDM4E B2RXH2 3/20 0.37
L3MBTL1 Q9Y468 2/20 0.34
KMT2A Q03164 4/20 0.34
MAPK1 P28482 1/20 0.34
TSPO P30536 5/20 0.33
MEN1 O00255 3/20 0.33
HTT P42858 2/20 0.33
ALDH1A1 P00352 2/20 0.33
USP2 O75604 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C9 P11712 1/20 0.33
TSHR P16473 1/20 0.33
LMNA P02545 1/20 0.33
POLB P06746 1/20 0.33
MAPT P10636 1/20 0.33
CYP1A2 P05177 1/20 0.33
GLA P06280 1/20 0.33
HPGD P15428 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13379434 0.85 KDM4E (0.40) CYP2C19KDM4EL3MBTL1KMT2AMAPK1
SCHEMBL13387698 0.79 PAK1 (0.41) CYP2C19KDM4EL3MBTL1KMT2AMAPK1
SCHEMBL12849639 0.77 MAPT (0.46) CYP2C19KDM4EL3MBTL1KMT2AMEN1
SCHEMBL16505479 0.75 KDM4E (0.56) KDM4EL3MBTL1KMT2AMAPK1MEN1
SCHEMBL21939652 0.75 ALDH1A1 (0.52) CYP2C19RIPK1KDM4EL3MBTL1KMT2A
SCHEMBL755479 0.75 MEN1 (0.50) CYP2C19KDM4EKMT2AMEN1HTT
SCHEMBL16008196 0.73 KDM4E (0.57) KDM4EL3MBTL1KMT2AMEN1HTT
SCHEMBL31547755 0.73 KDM4E (0.57) KDM4EL3MBTL1KMT2AMEN1HTT
SCHEMBL14723648 0.73 L3MBTL1 (0.34) CYP2C19KDM4EL3MBTL1KMT2AMEN1
SCHEMBL12798535 0.73 KDM4E (0.40) CYP2C19KDM4EKMT2ATSPOMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8383094-B2 inhibit the function of the NS5A protein encoded by Hepatitis C virus (HCV); useful in establishing or determining the binding site of other antiviral compounds, for example, by competitive inhibition; used to treat or prevent viral contamination of materials BRISTOL-MYERS SQUIBB COMPANY (US) 2013-02-26 US disclosed